Nebraska Oncology Society
Nebraska Oncology Society is a non-profit organization that has been in existence since 1992. Our mission is to facilitate and promote interaction among the oncology community to enhance patient care through oncology research, education, and health care legislation.
https://www.nebraskaoncology.org/
https://www.nebraskaoncology.org/
- 2024 Annual Midwest Regional Mid-Year Review
- 14th Annual Winter Breast Cancer Symposium
- 2023 Annual Midwest Regional Mid-Year Review
- 13th Annual Winter Breast Cancer Symposium
- 23rd Annual Midwest Regional ASCO Review
- 12th Annual Midwest Regional San Antonio Breast Cancer Symposium Review
- Annual Midwest Regional ASCO Review 2021
- Annual Regional Midwest ASCO Review 2020
- 11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review
- Evening Speaker Series
- Events
Playback speed
10 seconds
2020 ASCO Updates on GI Cancers: Is Chemo w/ mFOLFIRINOX More Effective vs. Gemcitabine/nab-Paclitaxel in Resectable PDAC? Should We Use 1L Donafenib vs. Sorafenib in Advanced HCC?
By
Nebraska Oncology Society
FEATURING
George Kim
By
Nebraska Oncology Society
FEATURING
George Kim
13 views
November 30, 2020
Comments 0
Login to view comments.
Click here to Login
Annual Regional Midwest ASCO Review 2020